Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 14/20 | 0.78 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | MAP3K12 | Q12852 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6867372 | 0.88 | ADORA2A (0.74) | ADORA2AMAPT | |
| SCHEMBL6867568 | 0.88 | ADORA2A (1.00) | ADORA2AHPGD | |
| SCHEMBL6869099 | 0.87 | ADORA2A (0.98) | ADORA2AHPGD | |
| SCHEMBL6871467 | 0.87 | ADORA2A (0.98) | ADORA2AHPGD | |
| SCHEMBL6869091 | 0.87 | ADORA2A (0.98) | ADORA2AHPGD | |
| SCHEMBL6867633 | 0.85 | ADORA2A (0.69) | ADORA2AHPGD | |
| SCHEMBL6863273 | 0.85 | ADORA2A (0.71) | ADORA2AALDH1A1LMNAHPGD | |
| SCHEMBL6867345 | 0.82 | ADORA2A (0.63) | ADORA2ARECQLALDH1A1HPGD | |
| SCHEMBL6863643 | 0.82 | ADORA2A (0.73) | ADORA2AALDH1A1LMNAHPGD | |
| SCHEMBL6871685 | 0.82 | ADORA2A (0.80) | ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6506772-B1 | Pharmaceutically active salts thereof with activity as adenosine receptor ligands are disclosed. These compounds are the adenosine receptor. | HOFFMANN-LA ROCHE INC. | 2003-01-14 | — | — | US | claimed |
| US-6506772-B1 | Pharmaceutically active salts thereof with activity as adenosine receptor ligands are disclosed. These compounds are the adenosine receptor. | HOFFMANN-LA ROCHE INC. | 2003-01-14 | — | — | US | disclosed |